PharmaCyte Biotech Releases Results of Shareholder Meeting and Provides Information on Upcoming Shareholder Update Call
LAGUNA HILLS, CA–(BUSINESS WIRE)—September 12, 2019 – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the results of the Special Shareholder Meeting and provides information on the shareholder update conference call scheduled for next week.
Read more →